Yes, Walk-In Lab provides direct-to-consumer testing without requiring physician referrals or prescriptions for most panels
Let our team know how we can help with your goals
Advanced stacks should only be considered after successfully completing simpler protocols
Investigational and emerging gastric inhibitory polypeptide (GIP) receptor-based therapies for the treatment of obesity
While Retatrutide shows enormous potential, many patients may benefit from available therapies today , including: GLP-1/GIP agonists (e.g., semaglutide, tirzepatide) Mitochondrial peptides like MOTS-c Adiponectin support through supplements, lifestyle, and insulin sensitizers Leptin-resistance protocols with personalized nutrition and inflammation control Rather than waiting for FDA approval, contact your clinic to discuss available options that best match your current health needs and goals
Our GLP-1 plotter can help visualize your progress over time